| NAME |
METOCLOPRAMIDE 15MG/SPRAY SOLN,NASAL,9.8ML |
| VA GENERIC NAME |
METOCLOPRAMIDE |
| DOSAGE FORM |
SOLN,NASAL |
| FDA MED GUIDE |
Metoclopramide_Nasal_(Gimoti)_(2020).pdf |
| HAZARDOUS TO DISPOSE |
NO |
| FORMULARY DESIGNATOR TEXT |
|
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
15 |
| SINGLE/MULTI SOURCE PRODUCT |
Multisource |
| UNITS |
MG/SPRAY |
| NATIONAL FORMULARY NAME |
METOCLOPRAMIDE SOLN,NASAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2020-09-22 00:00:00
|
| PGX ELIGIBLE |
YES |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
METOCLOPRAMIDE 15MG/SPRAY 112D NASAL INH |
| VA PRODUCT IDENTIFIER |
M1243 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
EA |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4039712 |
| EFFECTIVE DATE/TIME |
-
- 2020-09-22 00:00:00
- STATUS: ACTIVE
-
- 2020-09-22 00:00:00
- STATUS: ACTIVE
-
- 2020-09-22 00:00:00
- STATUS: ACTIVE
|